文献速递肿瘤 PET/CT核素与放射性配体治疗

肿瘤与血比值用于评估胰腺癌成纤维细胞活化蛋白受体密度:[68Ga]Ga-FAPI-04研究

Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-11-05

本研究纳入9例胰腺癌患者行[68Ga]Ga-FAPI-04全身PET/CT动态扫描,以药代动力学模型计算的总分布容积Vt为参照,评估肿瘤与血比值(TBR)对FAP表达半定量评估的价值。可逆两组织室模型(2TCM)最合适,病灶TBRmean与Vt强正相关(R2=0.92,P<0.001),TBRmean较SUVmean和SUVmax更好地反映FAP受体密度。

要点

  • 可逆两组织室模型(2TCM)是[68Ga]Ga-FAPI-04最合适的药代动力学模型。
  • 病灶TBRmean与2TCM模型Vt强正相关(R2=0.92,P<0.001)。
  • TBRmean较SUVmean和SUVmax更好地反映FAP受体密度。

核心结论

  • [68Ga]Ga-FAPI-04的TBRmean与Vt呈强正相关。
  • TBRmean较SUVmean和SUVmax更好地反映FAP受体密度,可能成为半定量评估肿瘤摄取和评价治疗反应的首选测量工具。

研究设计与样本

  • 9例胰腺癌患者注射[68Ga]Ga-FAPI-04后行60分钟动态PET/CT扫描,采用全身PET/CT(长轴视野194 cm)。
  • 动态扫描后3例患者接受化疗并再次行动态扫描以评估治疗反应。
  • 勾画原发胰腺病灶和转移灶感兴趣区获得时间-放射性曲线,用PMOD PKIN软件以四种房室模型拟合,基于赤池信息准则选择优选药代动力学模型。
  • 计算简化定量方法(SUV;肿瘤与血比值TBR)与药代动力学分析所得总分布容积Vt的相关性。

主要发现

  • 共评估9个原发病灶和25个转移灶。
  • 四种房室模型中可逆两组织室模型(2TCM)最合适。
  • 2TCM所得总分布容积Vt在病理病灶与背景区域间差异显著。
  • 病理病灶中TBRmean与2TCM模型Vt呈强正相关(R2=0.92,P<0.001)。
  • 接受化疗的患者中,TBRmean与Vt下降率的相对差异范围为2.1%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: [68Ga]Ga-FAPI PET/CT has been widely used in clinical diagnosis and radiopharmaceutical therapy. In this study, tumor-to-blood ratio (TBR) was evaluated as a powerful tool for semiquantitative assessment of [68Ga]Ga-FAPI-04 tumor uptake and as an effective index for tumors with high FAP expression in theranostics. METHODS: Nine patients with pancreatic cancer underwent a 60-min dynamic PET/CT scan by total-body PET/CT (with a long AFOV of 194 cm) after injection of [68Ga]Ga-FAPI-04. After dynamic PET/CT scan, three patients received chemotherapy and underwent the second dynamic scan to evaluate treatment response. Time-activity curves (TACs) were obtained by drawing regions of interest for primary pancreatic lesions and metastatic lesions. The lesion TACs were fitted using four compartment models by the software PMOD PKIN kinetic modeling. The preferred pharmacokinetic model for [68Ga]Ga-FAPI-04 was evaluated based on the Akaike information criterion. The correlations between simplified methods for quantification of [68Ga]Ga-FAPI-04 (SUVs; tumor-to-blood ratios [TBRs]) and the total distribution volume (Vt) estimates obtained from pharmacokinetic analysis were calculated. RESULTS: In total, 9 primary lesions and 25 metastatic lesions were evaluated. The reversible two-tissue compartment model (2TCM) was the most appropriate model among the four compartment models. The total distribution volume Vt values derived from 2TCM varied significantly in pathological lesions and background regions. A strong positive correlation was observed between TBRmean and Vt from the 2TCM model in pathological lesions (R2=0.92, P<0.001). The relative difference range for TBRmean was 2.1% compared to the reduction rate of Vt in the patients who were treated with chemotherapy. CONCLUSIONS: A strong positive correlation was observed between TBRmean and Vt for [68Ga]Ga-FAPI-04. TBRmean reflects FAP receptor density better than SUVmean and SUVmax, and would be the preferred measurement tool for semiquantitative assessment of [68Ga]Ga-FAPI-04 tumor uptake and as a means for evaluating treatment response.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chen R, Yang X, Yu X, et al. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging. 2022. PMID: 36334106. doi:10.1007/s00259-022-06010-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。